RR

Robby Ruijtenbeek

PB Pamgene B.V.: 8 patents #1 of 29Top 4%
ER Erasmus University Medical Center Rotterdam: 1 patents #63 of 114Top 60%
OH Oslo University Hospital Hf: 1 patents #47 of 65Top 75%
UB Universiteit Utrecht Holding B.V.: 1 patents #28 of 74Top 40%
📍 Utrecht, NL: #95 of 1,053 inventorsTop 10%
Overall (All Time): #622,761 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
11802315 Method for predicting the response of non-small-cell lung carcinoma patients to a medicament Dirgje Maria Adriana Van Den Heuvel, Richard De Wijn, Joan Gertrudis Jacobus Victor Aerts, Adrianus Henricus Josephus Mathijssen 2023-10-31
10604786 Method for predicting the response of melanoma patients to targeted pharmacotherapy Liesbeth Coosje Hovestad-Bijl 2020-03-31
9448237 Modified tyrosine amino acids, peptides containing them, and their use for detecting hydrolase enzyme activity Jeroen van Ameijde, Robertus Matthias Joseph Liskamp 2016-09-20
9128087 Nuclear receptor assay Rene Houtman, Marinus Van Beuningen 2015-09-08
9075061 Method for determining the estrogen receptor status of breast cancer Maria Helena Hilhorst, Arzu Umar, Johannes Albert Foekens, Johannes Wilhelmus Maria Martens 2015-07-07
8962268 Method for determining survival prognosis of patients suffering from non-small cell lung cancer (NSCLC) Richard De Wijn, Maria Helena Hilhorst 2015-02-24
8962267 Method for predicting the response of non-small cell lung cancer patients to targeted pharmacotherapy Richard De Wijn, Maria Helena Hilhorst, Michael Maria Van Den Heuvel, Houke Marian Klomp 2015-02-24
8617836 Method for predicting the response of locally advanced rectal cancer to chemoradiotherapy Pieter Jacob Boender, Richard De Wijn, Anne Hansen Ree, Sigurd Folkvord, Kjersti Flatmark 2013-12-31